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Abstract
We present a genome-wide method to map DNA double-strand breaks (DSBs) at nucleotide
resolution by direct in situ breaks labeling, enrichment on streptavidin, and next-generation
sequencing (BLESS). We comprehensively validated and tested BLESS using different human
and mouse cells, DSBs-inducing agents, and sequencing platforms. BLESS was able to detect
telomere ends, Sce endonuclease-induced DSBs, and complex genome-wide DSBs landscapes. As
a proof of principle, we characterized the genomic landscape of sensitivity to replication stress in
human cells, and identified over two thousand non-uniformly distributed aphidicolin-sensitive
regions (ASRs) overrepresented in genes and enriched in satellite repeats. ASRs were also
enriched in regions rearranged in human cancers, with many cancer-associated genes exhibiting
high sensitivity to replication stress. Our method is suitable for genome-wide mapping of DSBs in
various cells and experimental conditions with a specificity and resolution unachievable by current
techniques.
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DNA double-strand breaks (DSBs) can be caused by exogenous and endogenous physical
and chemical agents, and appear during apoptosis, meiotic crossing-over, and gene
rearrangements 1,2. Replication fork stalling and collapse also cause DSBs, and are
considered the major endogenous source of breaks in cycling cells 3,4. Unresolved DSBs
pose a serious threat to genomic stability, potentially leading to the formation of oncogenic
mutations, including translocations, deletions, and amplifications 2. Despite extensive
knowledge on mechanisms of DSBs sensing and repair, the genome-wide landscape of
DSBs in different cells and conditions remains largely unknown, mainly because of the lack
of methods to map DSBs with high specificity and resolution throughout the genome.
Chromatin immunoprecipitation (ChIP) coupled to microarray (ChIP-on-chip) or next-
generation sequencing (ChIP-seq) has been applied to map DSBs 5-7. However, the fact that
in ChIP-based methods DSBs are not directly labeled in situ, but rather detected indirectly
using antibodies targeting specific proteins that bind to DSBs, represents a considerable
source of bias. The phosphorylated histone variant H2A.X (γH2A.X) is typically used as a
marker of DSBs, but can also mark single-stranded breaks as well the inactive X
chromosome 8-10. Moreover, γH2A.X ChIP signals have been shown to spread tens of
kilobases away from a single DSB 11,12, making it difficult to map the exact position of a
DSB. Alternatively, the recruitment of replication protein A (RPA) has been used to map
DNA damage, but RPA accumulation is partially blocked by 53BP1 13,14, therefore limiting
the use of RPA to cells lacking 53BP1 for reliable results 15. Other approaches have used
capture or direct labeling of single-stranded DNA (ssDNA) followed by microarray analysis,
assuming ssDNA is a good proxy for DSBs 16-18. A bias in these methods, however, is that
ssDNA not converted to DSBs (for example, during replication) will yield false positive
results. Recently, a method based on breaks labeling with the terminal deoxynucleotydil
transferase (TdT) enzyme has been used to detect DSBs at defined locations in vitro and in
purified genomic DNA from S. cerevisiae 19. This method, however, has not been
implemented on a genomic scale, it is not in situ, and it does not allow labeling of DSBs
with specific barcode sequences, which would be extremely helpful in filtering next-
generation sequencing data. Therefore, more resolved and specific genome-wide methods
are needed to gain insights in the biology of DNA double-strand breaks in different cell
types and conditions. Here, we present a comprehensive experimental and computational
approach to directly map DSBs genome-wide, based on direct in situ breaks labeling,
enrichment on streptavidin, and next-generation sequencing (BLESS).
RESULTS
Method workflow
To avoid specificity issues associated with ChIP or TdT, we devised a protocol for specific
and direct in situ single-nucleotide resolution labeling and capture of individual DSBs in
nuclei purified from mammalian cells (Online Methods). Direct in situ labeling prevents
labeling of DSBs artificially formed during gDNA extraction, thus minimizing the risk of
false positives. After fixation to stabilize chromatin and prevent artificial DSBs, cells are
lysed and shortly incubated with proteinase K to purify intact nuclei. As a proof of concept,
we optimized this step using both human cell lines as well as mouse tissues from which
single-cell suspensions can be easily obtained (Supplementary Fig. 1a). After purification of
intact nuclei, DSBs are blunted, 5′-phosphorylated, and finally ligated to a biotinylated
linker (proximal) using the highly specific T4 ligase enzyme, which can only ligate double-
stranded but not single-stranded breaks. The linker forms a hairpin-like structure, and thus
can be ligated to either a blunt DSB or to an identical linker molecule, but cannot form
concatemers. The ligatable end of the linker consists of a barcode sequence marking the
exact position of ligation followed by the XhoI recognition site. Genomic DNA (gDNA) is
extracted and fragmented, and labeled fragments are captured by streptavidin. A second
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linker (distal) also containing the XhoI site is attached to the free extremity of captured
genomic fragments, enabling PCR amplification and sequencing (Fig. 1a-b). The use of
barcoded linkers is a powerful strategy to unequivocally mark DSBs, avoiding background
subtraction procedures as in ChIP data analysis.
Method implementation and validation
To implement our DSBs direct labeling and capture procedure, we performed pilot BLESS
experiments in HeLa cells and mouse B-lymphocytes, followed by Sanger sequencing and
next-generation sequencing on the Roche 454 platform. We performed various controls to
exclude substantial false positive labeling due to incomplete washout of proximal linkers,
unspecific binding of gDNA to streptavidin beads or mispriming. Only by following the
complete BLESS protocol, DNA fragments could be amplified and subjected to sequencing
(Supplementary Fig. 1b-d). 88% ± 6.5% (mean ± s.d., n = 2) of Roche 454 barcodes reads
contained both proximal and distal barcodes, whereas obly 1.5% ± 2% (mean ± s.d., n = 2)
contained the proximal barcode on both ends (Supplementary Table 1). As a first proof of
specificity, we searched for reads mapping in the immunoglobulin heavy chain (IgH) locus
among sequences derived from activated mouse B-lymphocytes. Upon B-lymphocyte
activation, DSBs are formed in the IgH donor Su region and the downstream acceptor S
region, enabling antigen class switch 20. Accordingly, the density of correctly barcoded
reads within these regions was significantly higher than the average read density in the
genome (2-fold enrichment, P = 0.02, hypergeometric test), even with the relatively modest
throughput achievable with the Roche 454 platform.
To increase data throughput, we performed deeper sequencing of BLESS samples using
Illumina GAII and HiSeq 2000 platforms (Supplementary Table 1). All sequencing data,
including Sanger and Roche 454 sequences, can be accessed at http://www.breakome.eu. In
single-end sequencing experiments, the proportions of proximal and distal barcodes among
barcoded reads were greatly similar (proximal 52.3% ± 9.8%, and distal 47.7% ± 9.8%,
mean ± s.d., n = 9). Pair-end sequencing confirmed that over 99% (99.3% ± 0.2%, mean ±
s.d., n = 2) of BLESS barcoded fragments contained both proximal and distal barcodes,
whereas less than 0.8% contained the same barcode on both ends (Fig. 1c and
Supplementary Table 1). This result demonstrates that the false positive DSBs labeling rate
in BLESS is lower than 1%. We initially deep sequenced HeLa cells – a model system for
which a large amount of genome-wide data is available and in which telomeric ends have
been well characterized 21. During BLESS, the 3′ G-overhang of unprotected telomeres –
which resembles a DSB repair intermediate 22 – is trimmed down to the first nucleotide of
the complementary C-strand, where the biotinylated linker is ligated (Supplementary Fig.
2a). Therefore, we expected accessible telomeric ends to be detected by BLESS.
Accordingly, we retrieved telomeric reads derived from the C-strand, with CTAACC being
the most frequent (73%) C-strand end, as previously reported 21 (Supplementary Fig. 2b).
We also deep sequenced U2OS cells carrying an I-SceI transgenic cassette, after transfecting
them with HA-I-SceI (SCE) to induce a single DSB per cell within this cassette
(Supplementary Fig. 2c). The density of barcoded reads inside the I-SceI cassette was almost
13,000 fold higher than the average read density in the genome (P = 6 × 10−300,
hypergeometric test), further validating our labeling method. These results demonstrate that
direct in situ labeling of DSBs followed by next-generation sequencing is an effective
strategy to identify DSBs at various genomic locations.
Genomic landscape of sensitivity to replication stress
Deep sequencing experiments revealed DSBs sparse throughout the genome, which from
now on we refer to as “breakome”. Cells grown in cell culture carry a non negligible amount
of DNA breaks caused by a combination of replication stress, physiological apoptosis, and
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damage induced by reactive oxygen species 12. Indeed, even in the absence of any
exogenous treatment HeLa cells carried a substantial burden of γH2A.X foci (mean = 3.8,
s.d. = 6.7 foci per nucleus, n = 300) (Supplementary Fig. 3a-b). In order to single out breaks
caused by replication stress, which are believed to be a major source of genome instability 3,
we exposed HeLa cells to a dose of aphidicolin – a DNA polymerase inhibitor – that induces
replication fork stalling without arresting progression in S-phase 23. This treatment resulted
in significant accumulation of breaks (P = 10−34, Kolmogorov-Smirnov test), and increased
the amount of labeled DSBs captured by BLESS (Supplementary Fig. 3a-d).
We analyzed aphidicolin sensitivity at various resolutions by comparing deep sequencing
data from replicates of samples treated (A) or not (C) with aphidicolin (Supplementary Fig.
4a). We analyzed the data by comparing read numbers within genomic windows with
constant mappable length in A vs. C samples, and calculated enrichment P values based on
the hypergeometric probability distribution. We computed final Q values based on the
Benjamini-Hochberg approach for multiple hypotheses testing 24 (Online Methods). We
mapped aphidicolin-sensitive regions (ASRs) at a resolution of 48 kilobases (kb) without
and with correction for copy number variation effects due to karyotype and aphidicolin
treatment (Supplementary Fig. 4b) which yielded 2,307 and 2,429 significantly correlated
ASRs, respectively (P = 10−323, hypergeometric test). To calculate the false discovery rate
(FDR) related to our approach, we analyzed reads that were mapped to the chromosome Y
through sequencing errors (in HeLa cells no reads from chromosome Y are expected). At 48
mappable kb resolution, the calculated FDR was 0.3%. The full list of ASRs and Q values is
available at http://www.breakome.eu.
ASRs were non-uniformly distributed along the genome, with an average of 3% of 48
mappable kb regions per chromosome sensitive to aphidicolin, except for chromosomes 5
and 7 which were significantly more sensitive (5%, P = 10−5, hypergeometric test) (http://
www.breakome.eu). As a comparison, we applied BLESS to HeLa cells treated with
neocarzinostatin – a DSBs-inducing drug presumed to yield a more “random” pattern of
breaks. Neocarzinostatin-sensitive regions were significantly more uniformly spread along
the genome (distance between consecutive sensitive regions: 0.54 ± 1.81 megabases (Mb)
and 0.21 ± 0.77 Mb for aphidicolin and neocarzinostatin, respectively, median ± s.d. P =
10−118, Kolmogorov-Smirnov test) (Fig. 2a and b). To validate our findings, we compared
several top-ASRs with regions displaying no appreciable aphidicolin effect using γH2A.X
ChIP. We observed a strong concordance between the aphidicolin effects measured in
targeted regions and BLESS results (Fig. 3a-b). Importantly, the genomic locations of ASRs
mapped in different experimental replicates were significantly correlated, demonstrating the
reproducibility of our method (Supplementary Table 2).
Characterization of aphidicolin-sensitive regions
It has been suggested that repetitive DNA sequences may favor fork stalling and collapse
upon replication stress, causing DSBs to appear more frequently at certain genomic
regions 3,4. In particular, repeats prone to form hairpin-like secondary structures might cause
the collapse of slowly moving replication forks by directly hindering their progression. To
investigate the association between repeats and aphidicolin sensitivity, we applied
RepeatMasker 25 to compute the abundance of various DNA repeat families inside ASRs as
compared to the rest of the genome (Online Methods). We detected a reproducible strong
and significant enrichment in satellites (P = 5 × 10−137) in particular of alpha-type (P = 8 ×
10−198, see Online Methods for derivation of P values), a class of repeats that forms hairpin-
like secondary structures and is abundant peri/centromeric regions (Fig. 4a, Supplementary
Fig. 5, and Supplementary Table 3). Accordingly, ASRs mapped at high resolution (250
mappable nucleotides) were concentrated in peri/centromeric regions (Supplementary Table
4). Another class of repeats, AT dinucleotides, has been associated with a particular group of
Crosetto et al. Page 4
Nat Methods. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
genomic regions sensitive to replication stress induced by aphidicolin – common fragile
sites (CFSs) 26,27. While many CFSs were scored as sensitive to aphidicolin following our
approach, AT repeats were significantly depleted in ASRs (P = 10−16, hypergeometric test).
During replication stress, slowly moving replication forks will have a higher chance of
colliding with transcriptional forks 28, resulting in accumulation of DSBs which may be
detected by BLESS. Accordingly, upon aphidicolin treatment, we detected a prominent
enrichment of DSBs in transcribed regions with the highest enrichment in coding regions (P
= 10−10, hypergeometric test). We next analyzed genes and ranked them based on the
computed probability to develop DSBs anywhere along their length. Top 20% aphidicolin-
sensitive genes showed significant enrichment of many gene ontology (GO) terms,
particularly related to cell death (P = 10−3, hypergeometric test). Gene sensitivity to
aphidicolin was significantly associated with gene length (P = 10−18, hypergeometric test),
in line with the observation that the probability of collisions between replication and
transcription forks in active genes seems to increase with gene length 28,29 (Supplementary
Fig. 6).
Finally, we investigated if ASRs mapped by BLESS are also associated with genomic
regions or genes frequently rearranged in human cancers. Replication stress-driven genomic
instability has been observed in many tumors, where it is thought to be an important cause of
cancer rearrangements 30,31. We used data from a cohort of over 2,700 human cancers 32,
and found a modest, but significant enrichment of regions displaying amplifications or
deletions inside ASRs as compared to the rest of the genome (P = 0.005, derived as
described in Online Methods) (Fig. 4b). We next compared aphidicolin-sensitive genes with
the Cancer Gene Census 33,34, a collection of over 400 well annotated cancer genes, the
majority of which is involved in translocations. Cancer genes were more likely to overlap
with ASRs than non-cancer genes (P = 0.04, hypergeometric test), and the fraction of genes
with 5′ end in 2 Mb vicinity of the center of a 48 mappable kb ASR, and containing that
ASR center inside, was higher for cancer genes than others (P = 0.02, hypergeometric test)
(Fig. 4c). Among most aphidicolin-sensitive genes, cancer genes were overrepresented (P =
0.04, hypergeometric test), including prominent oncogenes like EGFR, MET, ABL1, and
MLL, which are typically mutated by translocation or amplification (Fig. 4d). The full list of
genes ranked by aphidicolin sensitivity, and GO analysis results are available at http://
www.breakome.eu.
DISCUSSION
DNA double-strand breaks represent a major threat to genomic stability, and understanding
the sensitivity of the genome to various DNA insults will be instrumental to implement
effective preventive and treatment strategies. Chronic exposure to ionizing radiation is
common among several professionals, including medical radiation personnel, pilots and
flight attendants, as well as cosmonauts. Moreover, replication errors and reactive oxygen
species generated as by- products of metabolism have been estimated to cause breaks at a
frequency as high as fifty DSBs per cell per day 12. In spite of this pervasive threat, our
knowledge on how the genome breaks in response to various insults as well as our
technology to reliably detect DSBs are still in their infancy. In BLESS, DSBs are directly in
situ labeled with the highly specific enzyme T4 ligase with biotinylated oligonucleotides
that carry a defined barcode sequence. Unlike empirical background subtraction procedures
employed in ChIP-based methods to account for non-specific binding, direct DSBs labeling
in BLESS ensures high specificity of breaks detection, which can be then unambiguously
identified by the presence of barcode sequences. Another important advantage of BLESS
over ChIP-based methods is the ability to directly mark DSBs at nucleotide resolution in
situ, rather then relying on proxies such as γH2A.X which can be found thousand kilobases
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away from the actual original DSB 11. It should be noted that – at least for DSBs repaired by
homologous recombination – labeling can occur away from the initial breakpoint due to 5′
end resection. This property can be exploited by inducing DSBs at known genomic positions
(analogous to U2OS cells used in this study), obtaining a zoom-in view into the kinetics of
DSBs repair in vivo, and how this is influenced by the genomic context.
Our method is general and organism-independent, providing genome-wide maps of DSBs
for multiple cell types and conditions. Our computational methods and software tools allow
to obtain and analyze high-confidence genome-wide DSBs maps, and to account for copy
number variation effects attributable to the karyotype of cells analyzed and/or the effects of
the treatment used to induce DSBs. Our results demonstrate that hypothesis-driven feature
analysis of genomic regions identified by BLESS as sensitive to a specific treatment can
help explore the basis of genomic instability at a genome-wide level. In the future, our
method could be combined with ultra-deep sequencing of selected regions enriched, for
example, by exome capture 35 or reduced representation sequencing 36, thus providing a
high-definition picture of the sensitivity of specific regions to DSBs-inducing agents.
Finally, the design principle of BLESS could also be exploited for in situ DSBs labeling and
visualization by super-resolution microscopy. The labeling method and the computational
approaches described here represent a valuable resource for the DNA damage research
community, providing tools to map and analyze breakomes in a variety of organisms and
conditions with a precision and resolution currently unattainable with other methodologies.
ONLINE METHODS
Cells, reagents, and immunocytofluorescence
To obtain primary mouse single-cell suspensions, we squeezed testes and spleens from
C57BL6/J mice between two microscope slides in a Petri dish filled with trypsin. We
flushed bone marrow out of femurs and tibias from the same animals using a syringe filled
with trypsin. We purified and activated B-lymphocytes as previously described 37. Prior to
fixation for BLESS, we removed dead cells using a Ficoll gradient. We filtered cell
suspensions through MACS Pre-Separation filters (Milteniybiotec), and then fixed them
according to the BLESS protocol. We obtained IMR90 primary fibroblasts and HeLa cells
from ATCC, and U2OS_DRH-1 cells from Y. Shiloh (Tel Aviv University). Andrew J.
Pierce (University of Kentucky) kindly communicated details on the construction of
U2OS_DRH-1 cells. We transfected pcBAS-I-SceI and pCAGGs plasmids (kindly donated
by Y. Shiloh) into U2OS_DRH-1 cells using Fugene (Roche) following the manufacturer’s
instructions. After BLESS, we cloned gDNA fragments into pEGFP-C1 (BD Biosciences).
We applied aphidicolin (Sigma) onto cells at 0.4 μM for 18 h, and neocarzinostatin (Sigma)
at 200 ng/ml for 45 min. We obtained oligonucleotide linkers from Sigma and annealed
them in 1× T4 ligase buffer (NEB). Linkers and primers used are listed in Supplementary
Table 5. We visualized γH2A.X foci by immunocytofluorescence (Millipore # 05-636), and
counted them as previously described 38.
Breaks Labeling, Enrichment on Streptavidin, and Sequencing (BLESS)
A detailed, step-by-step protocol to perform BLESS can be found in the supporting webpage
http://www.breakome.eu. Briefly, to prepare purified nuclei for in situ ligation, we fixed five
million cells as single-cell suspensions in growth medium with 2% formaldehyde for 30 min
at room temperature, and then washed them one time in ice-cold 1× PBS. To prepare single-
nucleus suspensions, we first lysed fixed cells in a buffer containing 10 mM Tris-HCl, 10
mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.2% NP-40 pH 8 for 90 min at 4 °C, and then in a
buffer containing 10 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.3% SDS
pH 8 for 45 min at 37 °C. We resuspended lysed cells in 1× NEBuffer 2 (NEB)
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supplemented with 0.1% Triton X-100 and Proteinase K at 100 μg/ml final concentration.
We mildly rotated cells for a short time at 37 °C (8 min for HeLa, 4 min for mouse B-
lymphocytes), after which we transferred them onto ice. We quenched proteinase K by
adding an equal volume of buffer supplemented with PMSF.
We washed purified nuclei twice in 1× NEBuffer 2 supplemented with 0.1% Triton X-100,
and then once in blunting buffer (NEB) supplemented with 100 μg/ml BSA. We performed
blunting using the Quick Blunting kit (NEB) according to the manufacturer’s instructions in
a final volume of 100 μl, for 45 min at room temperature. Afterwards, we washed nuclei
twice in 1× NEBuffer 2 supplemented with 0.1% Triton X-100, once in 1× T4 ligase buffer
supplemented with 0.1% Triton X-100, and once in 1× T4 ligase buffer. We performed in
situ ligation for 18-20 h at 16 °C in 25 μl final volume using 1.5 μl of T4 ligase (NEB) and
5 μl of 10 μM proximal linker previously annealed in 1× ligase buffer. After ligation, we
washed nuclei three times ina high-salt buffer (W&B) containing 5 mM Tris-HCl, 1 mM
EDTA, 1 M NaCl pH 7.5 supplemented with 0.1% Triton X-100. Afterwards, we extracted
gDNA by incubating nuclei in 1× NEBuffer 2 with 0.5% Triton X-100 and Proteinase K at
200 μg/ml final concentration for one hour at 65 °C shaking, followed by isopropanol-
ethanol purification. We fragmented purified gDNA for 18-20 h at 16 °C using 6 U of
HaeIII (NEB) every million cells fixed.
To capture labeled DSBs, we rotated 20 μg of purified gDNA with 5μl of Dynabeads
MyOne C1 (Invitrogen) in W&B buffer supplemented with 0.1% Triton X-100 for 30 min at
+4 °C. Afterwards, we washed beads three times in W&B buffer supplemented with 0.1%
Triton X-100, and them resuspended in 37 μl of 1× T4 ligase buffer. We added 10 μl of
distal linker previously annealed at 10 μM in 1× ligase buffer, and 3 μl of T4 ligase to the
beads, and the reaction was carried on for 16-18 h at 16 °C. After distal linker ligation, we
washed beads twice in W&B buffer supplemented with 0.1% Triton X-100 at room
temperature, and then digested captured fragments with I-Sce (NEB) in 25 μl final volume
for 4 h at 37 °C. Afterwards, we centrifuged beads, and stored the supernatant at 20 °C until
PCR.
We used all the volume of supernatant after I-Sce digestion to prepare multiple PCR
amplification reactions (5 μl per reaction) using Phusion polymerase (NEB) and the
appropriate primers pair depending on the downstream sequencing platform (Supplementary
Table 5). We performed eighteen amplification cycles using conditions recommended by the
manufacturer and Ta = 55 °C. To remove unused primers, we purified PCR products in gel
using the DNA Gel Extraction kit (Qiagen). Before Illumina library preparation, we digested
purified PCR products with XhoI (NEB) to cleave terminal I-SceI sequences derived from
linkers, and again gel-purified them.
Next-generation sequencing
Sequencing was either outsourced (imaGenes GmbH, Berlin, Germany, and ServiceXS,
Leiden, Netherlands) or performed in-house as summarized in Supplementary Table 1. We
prepared samples for Roche 454 sequencing using indexing barcodes-containing primers
during the PCR step in BLESS (Supplementary Table 5). We purified PCR products of size
comprised between 300 and 800 nt in gel, and analyzed them on the 2100 Bioanalyzer
(Agilent) prior to sequencing. For BLESS Illumina library preparation, we used the TruSeq
DNA sample preparation kit v2 (Illumina) without DNA fragmentation and library size
selection. For gDNA sequencing, we sheared gDNA with Covaris S220 AFA (Covaris)
according to the manufacturer’s instructions prior to Illumina library preparation. We
assessed library quality and quantity on the 2100 Bioanalyzer (Agilent) using the High
Sensitivity DNA Kit (Agilent), and by qPCR with the Kapa Library quantification Kit
(KapaBiosystems). We generated clusters on the Illumina flow cell using the automatic cBot
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station and the TruSeq PE Cluster Kit v3-cBot-HS. We carried out sequencing by synthesis
on Illumina HiSeq 2000 system using the TruSeq SBS Kit v3-HS chemistry.
ChIP and qPCR
We performed ChIP assays as previously described 39, with minor modifications. We
purified immuno-precipitated and input DNA with phenol-chloroform, and analyzed it by
real-time qPCR using primers listed in Supplementary Table 6. We compared the amount of
DNA captured in untreated vs. aphidicolin-treated HeLa cells by qPCR followed by data
analysis according to the ΔCt method 40, using the Ct values obtained for each primer pair in
sample C1 as a reference for the Ct values obtained for the same primer pair in sample A1.
We used three technical replicates for each sample. Primers are listed in Supplementary
Table 7.
Computational analyses
Roche 454 data—We analyzed Roche 454 data using previously described scripts
developed in the Chiarle lab 37 adapted for BLESS linkers. Briefly, we aligned sequences to
the mouse reference genome (GRCm38/mm10) using BLAT, and subsequently filtered them
for the BLESS proximal linker using BLAST. We further processed filtered reads to remove
PCR repeats (including repeats slightly divergent due to sequencing errors), invalid
alignments (including alignment scores < 30, reads with multiple alignments having a score
difference <4, and alignments having ≤ 10 nt gaps), and linker ligation artifacts (for
example, random HaeIII restriction sites ligated to proximal linker).
Illumina data—We analyzed Illumina data using the Instant-seq software suite developed
in the Rowicka Lab. We filtered reads from fastq files requiring a Phred score ≥ 20 for every
base, and trimmed them at the point where the Phred score of an examined base fell below
20. We retained all reads with length ≥ 34 nt as high-quality filtered reads, and scanned
them for the presence of the exact proximal or distal barcode. After removal of barcodes, we
aligned reads ≥ 23 nt to the GRCh37/hg19 assembly of the human genome. We only
retained sequences mapping without mismatches to unique (U0) or multiple (R0) positions.
To identify aphidicolin-sensitive regions (ASRs), we compared the number of reads in A
(aphidicolin-treated) and C (untreated) samples using windows with constant number of
mappable bases to account for the variation in mappability along the human genome, and
produce more statistically robust comparisons of the number of reads between different
windows. As a comparison, we also used windows of constant length, demonstrating that
our approach is not biased towards detecting ASRs in repetitive regions (Supplementary Fig.
7a-b). Using a pre-computed mappability map corresponding to 45 nt reads, we moved
windows of chosen mappable length across each chromosome, and calculated enrichment P
values based on the hypergeometric probability distribution. The parameters for calculating
hypergeometric P values were the following: (i) total number of mapped reads in
experiments A and C; (ii) total number of mapped reads in experiment A; (iii) total number
of mapped reads in the sliding window in experiments A and C; (iv) total number of mapped
reads in the sliding window in experiment A only. We computed final Q values using the
Benjamini-Hochberg correction for multiple hypotheses testing 24. We first analyzed
individual sample replicates (A1 vs. C1; A2 vs. C2; A3 vs. C3; A4 vs. C4), and found that
ASRs were highly correlated (Supplementary Table 2). Therefore, for all subsequent
analyses, we pooled samples so that C = (C1 + C2 + C3 + C4) and A = (A1 + A2 + A3 +
A4). To account for copy number variation effects due to karyotype or aphidicolin
treatment, we sequenced gDNA derived from normal human fibroblasts (g-F), HeLa (g-C),
and HeLa treated with aphidicolin (g-A), and mapped it to the human reference genome
(GRCh37/hg19) (Supplementary Table 1). Using windows with constant number of
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mappable bases, we first calculated the expected number of reads in each window based on
the g-F sample, and then compared it to normalized reads obtained from g-C and g-A
samples. If the ratio of reads was higher or lower than the expected number, we computed
the P value of the corresponding enrichment or depletion. P values were then corrected for
multiple hypotheses testing using Benjamini-Hochberg correction 24, and significantly
enriched windows (P ≤ 0.05) were finally annotated as high-confidence, karyotype- and
aphidicolin-corrected ASRs. We applied the same procedure to identify neocarzinostatin-
sensitive regions (NSRs).
To compute gene sensitivity to aphidicolin, we obtained the start and end coordinates of
each gene annotated in GencodeV12 by linearly combining all annotated transcripts. We
analyzed each gene by using the same approach described above for ASRs, using the start-
end coordinates of the gene as the start-end coordinates of genomic windows. Genes that did
not have any mappable bases within the boundaries of the window were not analyzed. We
inferred the relationship between aphidicolin sensitivity and gene length by computing rank
correlation. We also computed the overlap between genes and ASRs, by agglomerating
results from fifty different ASR maps with resolutions in the range of 10-60 mappable kb.
For each window length, we first calculated the percentage overlap of a gene with ASRs,
and then averaged percentages over all lengths. To assess the significance of overlap
enrichment, we computed the distribution of averaged overlap for each gene. We calculated
the exact distribution under the assumption that the aphidicolin sensitivity of each window is
independently assigned, with probability depending on its length (a different percentage of
windows was aphidicolin-sensitive for different window sizes as shown in Supplementary
Fig. 4a). We computed the exact distribution step-by-step for consecutive window lengths
using dynamic programming. Based on this distribution, we calculated for each gene the P
value of its overlap enrichment, and then applied Benjamini-Hochberg multiple hypotheses
testing correction 24 to the whole gene lists. We compared ASRs enrichment in cancer-
associated genes vs. all genes using both the Kolmogorov-Smirnov and hypergeometric test,
obtaining the same result (P = 0.04). Finally, we identified genes that have transcripts with
5′ end within 2 Mb vicinity of an ASR center using the Gencode annotation of genes. We
extracted locations of all transcripts, and for each ASR we identified transcripts in its
proximity, and calculated the distance from the center of the ASR to the transcription start
site. We analyzed the list of transcripts within 2 Mb distance of an ASR, and reported the
corresponding gene along with the exact distance and ASR center location (within or
outside). This list was binned at various intervals of distances. Finally, we analyzed the list
of transcripts in vicinity of ASRs and outputted a list of gene groups binned according to the
distance from the center of the ASR to the closest transcription start site (Fig. 4c). We
computed statistics for differences between groups using the hypergeometric probability
distribution.
For biological characterization of ASRs, we created feature datasets from RepeatMasker 25
and from the CpG Islands tracks of UCSC Genome Browser 41 and genome-wide summary
data of Tumorscape portal 42. We obtained cancer-associated genes from the Sanger
Institute’s Cancer Gene Census 33,34. When required, we mapped genome coordinates to the
GRCh37/hg19 assembly of the human genome using liftover. As repetitive regions tend to
be underrepresented among uniquely mapped reads, we corrected for differences in
mappability. To determine if a given genomic feature is enriched in ASRs, we computed the
proportion of mappable nucleotides belonging to both ASRs and the feature, as well as the
proportion of ASRs among all the intervals considered. Next, we performed 100,000
permutations of ASR assignments among the windows considered. Based on these
permutations, we calculated the empirical distribution of the ratio under the null hypothesis
that the given feature and ASRs are independently distributed in the human genome. We
used this distribution to estimate the P value for the feature enrichment inside ASRs. This
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method yielded a P value resolution of 10−5, which was too low for features particularly
well correlated with fragility (Supplementary Table 3). In such cases, we analyzed empirical
ratio distributions. We observed that the normal distribution fits well for long windows (48
mappable kb). For short windows (250 and 2,000 mappable nt), the number of ASR
mappable nucleotides within featured regions was almost always the integer multiple of the
window length, and multiplication factors followed the geometric distribution. Thus, we
analytically determined P values according to these distributions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
BLESS workflow and specificity. (a) DSBs are ligated in situ to a proximal linker (red arch)
covalently linked to biotin (orange oval) (1), gDNA is extracted and fragmented (2), and
labeled fragments are captured on streptavidin beads (gray ovals) (3). A distal linker (blue
arch) is then ligated to the free extremity of captured fragments (4), and fragments are
released by linker digestion with I-SceI (5). Released fragments are amplified by PCR using
linker-specific primers (6), and sequenced (7). (b) Structure of linkers. Both proximal (P)
and distal (D) linkers share an XhoI site (yellow), the I-SceI endonuclease minimal
recognition site (non-highlighted letters), and a seven-thymine loop (bold). Each linker
contains a specific barcode sequence marking the ligation site (orange and brown). The
proximal linker is biotinylated (orange oval). (c) Proportion of fragments with proximal (P)
and distal (D) barcodes in single-end (SE) and pair-end (PE) Illumina sequencing
experiments. Mean ± s.d. is shown.
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Figure 2.
Example of HeLa breakomes associated with specific treatments. (a) Genome-wide
aphidicolin (orange) and neocarzinostatin (gray) sensitivity landscapes in HeLa cells,
corrected for karyotype and aphidicolin effects. Bars represent the density per one Mb bin of
48 mappable kb ASRs corrected for copy number variation effects. Individual regions and
mappability maps are shown in detail in Supplementary Fig. 4b, since non-mappability can
artificially lower the number of significant regions per Mb. (b) Frequency distribution of
genomic distances between the centers of consecutive aphidicolin- and neocarzinostatin-
sensitive regions.
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Figure 3.
ASRs validation. (a) Fraction of input DNA captured by ChIP in regions with significant
(grey highlight) vs. non-significant aphidicolin effect in HeLa cells treated (orange) or not
(green) with aphidicolin. Mean ± s.d. are shown for n = 3 biological replicates. Genomic
coordinates of amplicons analyzed by qPCR are reported. Chr: chromosome. Coord:
genomic coordinate. (b) Comparison of aphidicolin effect measured by BLESS vs. ChIP in
regions described in (a). Captured DNA ratio: ratio of captured DNA in aphidicolin-treated
(A) vs. control (C) HeLa. R: Pearson’s correlation coefficient.
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Figure 4.
Biological characterization of ASRs. (a) Satellite repeats significantly enriched within 48
mappable kb ASRs in comparison to the rest of the genome. Repeat names follow the
nomenclature in RepeatMasker 25. Bars: enrichments calculated based on (A1 + A2 + A3 +
A4) vs. (C1 + C2 + C3 + C4) pooled samples. Diamonds: enrichments calculated based on
(A1 + A2) vs. (C1 + C2) pooled samples. Dashed lines represent average genome-wide
enrichment. (b) Significant enrichment of cancer-associated somatic copy number
alterations. All: all alterations. Amp: amplifications. Del: deletions. Dashed lines represent
average genome-wide enrichment. (c) Percentage of cancer (red) and non-cancer (blue)
genes containing the center of a 48 mappable kb ASR within 2 Mb downstream from the 5′
end. (d) Ranking of aphidicolin-sensitive cancer-associated genes by decreasing sensitivity,
expressed as percentage of the most sensitive gene on the left.
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